Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
Crossref DOI link: https://doi.org/10.1007/s12325-015-0262-9
Published Online: 2015-11-17
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jain, Rajeev
Funding for this research was provided by:
AstraZeneca LP